Netscientific PLC
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Third Quarter 2022 Financial Results and Business Update NetScientific Plc (AIM: NSCI), the international…
NetScientific plc (“NetScientific” or “NSCI” or the “Company” or the “Group”) Board Change London, UK – 9 November 2022: NetScientific Plc (AIM: NSCI),…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Completes $35 Million Financing Agreement Led By Horizon Technology Finance NetScientific plc…
NetScientific plc ("NetScientific", the "Group" or the "Company") Completion of acquisition of 30% stake in Vortex Biotech Holdings (Vortex) and appointment…
RNS Reach - Non-Regulatory Announcement NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Reports Second Quarter 2022 Financial…
NetScientific plc Director/PDMR Shareholding NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation group, announced on 22 June 2022, that…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR…
THE INFORMATION IN THIS ANNOUNCEMENT, WHICH INCLUDES CERTAIN INFORMATION DRAWN FROM PUBLIC SOURCES, DOES NOT PURPORT TO BE COMPREHENSIVE AND HAS NOT…
RNS REACH NetScientific plc ("NetScientific", the "Group" or the "Company") NetScientific to increase Q-Bot stake to 23.7% NetScientific plc (AIM: NSCI),…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Q-Bot Limited (“Q-Bot”) secures £1.6m of investment to fund growth NetScientific plc (AIM:…
NetScientific plc (“NetScientific” or the “Company”) Notice of AGM and Annual Report & Accounts London, UK – 07 June 2022…
06 June 2022 NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotechnology Granted FDA Fast Track Designation for Lead Candidate PDS0101…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech presents new data for two ongoing clinical trials NetScientific plc (AIM:…
NetScientific plc (“NetScientific” or the “Company”) General Counsel Strategic Hire and Grant of Options NetScientific plc (AIM: NSCI), the international life…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) ProAxsis Update ProAxsis announces “impressive” results in performance evaluation of the in-licensed AstraZeneca…
NetScientific plc ("NetScientific", “NSCI”, the Group” or the "Company") Preliminary Results for the year ended 31 December 2021 Good results demonstrate…
11th May 2022 NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial…
NetScientific plc ("NetScientific", the "Group" or the "Company") Notice of Results Investor Presentation NetScientific plc (AIM: NSCI), the international life sciences and…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Acquisition of 30% of Vortex Biotech Holdings NetScientific plc (AIM: NSCI), the international…
NetScientific plc ("NetScientific" or the "Group") PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2021 Financial Results London, UK –…
NetScientific Q1 2022 Newsletter (Click to view full Newsletter) Dear NetScientific PLC Shareholders and Stakeholders, In advance of the annual report…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Preliminary Safety Data on PDS0101 in Combination With Merck’s anti PD-therapy…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Clinical Trial with Mayo Clinic PDS Biotech Announces Clinical Trial with Mayo…
NetScientific plc ("NetScientific", the "Group" or the "Company" PDS Phase 2 Trial Update PDS Biotech Announces Preliminary Efficacy Achievement in…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Preclinical Data for PDS0202 Universal Influenza Vaccine London, UK – 28…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Granted Patent for its Novel HPV16 Immunotherapy London, UK – 10…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) ProAxsis CEO End of Year Update London, UK – 10 January 2022 – NetScientific plc (AIM:…
TR-1: Standard form for notification of major holdings Issuer Details ISIN GB00B9F4MT28 Issuer Name NETSCIENTIFIC PLC UK or Non-UK Issuer UK Reason…
NetScientific plc ("NetScientific", the "Group" or the "Company") Q-Bot Investment and Share Acquisition NetScientific takes c.19% direct stake in construction industry robotics…
NetScientific plc ("NetScientific", the “Group” or the "Company") Acquisition of majority stake in Cetromed Investment in Cetromed subsidiary FOx Biosystems NetScientific…
NetScientific plc ("NetScientific", the “Group” or the "Company") Martlet Capital Update EMVC syndicates additional £0.73m investment Syndication highlights strength of capital…
NetScientific plc ("NetScientific", the “Group” or the "Company") $1million investment in portfolio company, EpiBone London, UK – 26 November 2021 – NetScientific…
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS Provides Business Update and Reports Q3 2021 Financial Results London, UK –…
NetScientific plc ("NetScientific", the “Group” or the "Company") Sofant Signs €7.3m European Space Agency Contract London, UK – 4 November 2021 – NetScientific…
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS Biotech Announces Agreement with University of Georgia to License Novel Proteins for Versamune-based…
NetScientific plc ("NetScientific", the “Group” or the "Company") EMV Capital participates in £843k funding for 5G and satellite phased array antenna designer…
ProAxsis is delighted to announce the approval of a key US patent for the underlying technology associated with its brand-new K-POSTN Assay,…
ProAxsis, one of NetScientific's portfolio companies specialized in the Life Sciences sector, has just presented its new NEATstik product which has been…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
NetScientific plc ("NetScientific" or the "Company") Director/PDMR Shareholding London, UK – 16 July 2021 – NetScientific plc (AIM: NSCI), the international life sciences…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Closing of Approximately $52 Million Public Offering and Full Exercise…
The latest data points to a 71% response rate to the drug
Chairman John Clarkson said: “In what has been a challenging year for ProAxsis, positive management actions have helped transform the company’s outlook"
The City broker pointed to the last fair value calculation for the assets held by the investment company, which specialises in life sciences and…
It is envisaged that the validation and initial commercialisation can be achieved largely from ProAxsis' existing resources
“The data provide early evidence of notable clinical activity, and we saw effective tumour regression in these patients"
"This placement provides further impetus behind our model of 'capital-light' investment combined with pro-active management and value-added support to our portfolio," said…
NetScientific currently has a 5.7% stake in PDS Biotechnology, which is at the cutting edge of immuno-oncology
WHI Ireland has a sum-of-the-parts valuation for the shares of 162p - a 40% premium to the current price
NetScientific plc ("NetScientific", the "Group" or the "Company") NetScientific participates in PDS Biotechnology $45m equity issue and related party transaction London,…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Proposed Offering of Common Stock London, UK – 15…
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN ARE RESTRICTED AND ARE NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR…
THE INFORMATION IN THIS ANNOUNCEMENT, WHICH INCLUDES CERTAIN INFORMATION DRAWN FROM PUBLIC SOURCES, DOES NOT PURPORT TO BE COMPREHENSIVE AND HAS NOT…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical…
NetScientific plc ("NetScientific" or the "Group") ProAxsis Update ProAxsis signs global in-licensing agreement with AstraZeneca for COVID-19 serology test London, UK –…
NetScientific plc ("NetScientific", the “Group” or the "Company") Result of AGM London, UK – 3 June 2021 – NetScientific plc (AIM: NSCI),…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
NetScientific plc ("NetScientific" or the "Group") ProAxsis Update Following transformative year ProAxsis focuses on delivering revenues and profitability London, UK – 24…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Release of Abstract for PDS0101 in NCI-Led Phase 2 Clinical Study…
NetScientific plc ("NetScientific", the "Group" or the "Company") EMV Capital advises on £3.4m funding for smart sensor maker PointGrab London, UK…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results London,…
NetScientific plc ("NetScientific", the "Group" or the "Company") EMV Capital advised on £2.9m funding for anaesthetic gas recycling tech business SageTech…
NetScientific plc ("NetScientific", the "Group" or the "Company") PDS Biotech Announces Oral Presentation of PDS0101 Data by the National Cancer Institute at…
NetScientific plc ("NetScientific", the “Group” or the "Company") EMV Capital advised on £740k oversubscribed funding round for 5G and satellite phased array…
NetScientific plc (“NetScientific” or the “Company”) Notice of AGM and Annual Report & Accounts London, UK – 14 April 2021…
NetScientific plc ("NetScientific", “NSCI”, the Group” or the "Company") Preliminary Results for the year ended 31 December 2020 Company poised for further…
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS Biotechnology Reports Final Results for the Full Year 2020 & Business Update …
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS COVID-19 Vaccine Commercialisation Update c. $60m Funding Commitment by Brazilian government for Clinical…
NetScientific plc ("NetScientific", the “Group” or the "Company") PDS COVID-19 Vaccine Commercialisation Update Blanver joins PDS-Farmacore COVID-19 Vaccine Consortium …
NetScientific plc ("NetScientific" or the "Company") ProAxsis Update London, UK – 22 February 2021 – NetScientific plc (AIM: NSCI), the life sciences and…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Preliminary Efficacy Achievement in Phase II Combination Trial of PDS0101 Led by…
NetScientific plc ("NetScientific" or the "Company") Suspension of Trading on AIM NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation…
NetScientific plc ("NetScientific" or the "Company") Issue of Shares, Director/PDMR Shareholding and Total Voting Rights NetScientific plc (AIM: NSCI), the life sciences,…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19…
NetScientific plc ("NetScientific" or the "Company") ProAxsis Limited awarded Innovate UK grant to utilise company technology to identify high risk COVID-19 patients…
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Board changes and grant of Options London, UK – 2 December 2020 –…
NetScientific plc (“NetScientific” or the “Company”) NetScientific’s EMV Capital Ltd leads a £1.28m pre-Series A round in SageTech Medical Equipment Ltd…
NetScientific plc ("NetScientific" or the "Company") ProAxsis Limited appoints DiaPharma as distributor to key North America region London, UK – 19 November…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech and Farmacore Announce Updates to Co-Development of Versamune®-Based COVID-19 Vaccine PDS0203 prioritized for clinical…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Initiates VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent/Metastatic Head and Neck…
NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Initiation of Phase 2 Trial of PDS0101 in Combination with Standard of Care…
NetScientific plc ("NetScientific" or the "Company") NetScientific plc NetScientific acquires 100% control of portfolio company ProAxsis Limited London, UK – 16 October…
NetScientific plc ("NetScientific" or the "Company") Grant of Options to Director London, UK – 25 September 2020 – NetScientific plc (AIM:NSCI) (the "Company"), the…
NetScientific plc (“NetScientific” or the “Company” or the “Group”) Interim Results for the six months ended 30 June 2020 London, UK…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
NetScientific plc ("NetScientific" or the "Company") Result of General Meeting NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, is pleased to…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
NetScientific plc ("NetScientific" or the "Company") Issue of Equity NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that to…
NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology Corporation Announces Closing of Approx. $19 Million Public Offering and Full Exercise of Underwriter's…
NetScientific plc ("NetScientific" or the "Company") Sofant Technologies Ltd secures £2.3m in an oversubscribed funding round led by EMV Capital NetScientific plc…
NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology Corporation Announces Pricing of $16.5 Million Public Offering of Common Stock NetScientific plc (AIM:NSCI),…
NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology Corporation Announces Proposed Public Offering of Common Stock NetScientific plc (AIM:NSCI), the transatlantic healthcare…
NetScientific plc ("NetScientific" or the "Company") Posting of shareholder circular Further to its announcement of 5 August 2020, NetScientific plc (AIM:NSCI),…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART,…
THE INFORMATION IN THIS ANNOUNCEMENT, WHICH INCLUDES CERTAIN INFORMATION DRAWN FROM PUBLIC SOURCES, DOES NOT PURPORT TO BE COMPREHENSIVE AND HAS NOT…
NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology Announces Preclinical Data for PDS0203, a T-Cell Activating Recombinant Protein Vaccine Against COVID-19 Versamune-CoV-2…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Collaborator Granted NIAID Award to Accelerate Development of Versamune®-Based Universal Influenza Vaccine London,…
NetScientific plc (“NetScientific” or the “Company”) G – Tech Medical, Inc. (“G – Tech”) announces completion of $6.7m Series A financing round…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
NetScientific plc (“NetScientific” or the “Company”) Result of 2020 Annual General Meeting London, UK – 24th June 2020 – NetScientific plc…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine London, UK – 18…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Announces initiation of Phase 2 Trial of PDS0101 Led by the National Cancer Institute…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotech Announces Clinical Trial of Its Lead Immunotherapy Product, PDS0101, in Combination with Chemoradiotherapy in…
NetScientific plc (“NetScientific” or the “Company”) Notice of AGM London, UK – 1 June 2020 – NetScientific plc (AIM:…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or the “Company”) PDS…
NetScientific plc (“NetScientific” or the “Company”) Confirmation of Board Changes London, UK – 1 May 2020 – NetScientific plc (AIM: NSCI), the…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Expands CRADA with the National Cancer Institute to Include Second Versamune®-Based Anti-Cancer Product …
NetScientific plc ("NetScientific" or the "Group") NetScientific Full Year Preliminary Results for the year ended 31 December 2019 London,…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Initiates Novel Vaccine Development Programs For COVID-19 and Universal Influenza; Delay of PDS0101 VERSATILE-002…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology Appoints Dr. Ilian Iliev to Board of Directors London, UK – 14 April…
NetScientific plc (“NetScientific” or the “Company”) Board Changes London, UK – 31 March 2020 – NetScientific plc (AIM: NSCI), the transatlantic healthcare…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying issuer…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology equity issue and related party transaction London, UK – 12 February 2020: NetScientific plc…
NetScientific plc (“NetScientific” or the “Company”) PDS Biotechnology proposed offering London, UK – 11 February 2020: NetScientific plc (AIM: NSCI), the…
NetScientific plc (“NetScientific” or the “Company”) Board Change Resignation of Ian Postlethwaite as CEO, CFO and Company Secretary London, UK – 15…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying…
NetScientific plc (“NetScientific” or the “Company”) Board Changes London, UK – 13 December 2019 – NetScientific plc (AIM: NSCI), the transatlantic healthcare…
NetScientific plc (“NetScientific” or the “Company”) Portfolio Company Glycotest Inc. receives the second $3 million tranche of the $10 million Series…
NetScientific plc (“NetScientific” or the “Company”) Appointment to the Board London, UK – 14 October 2019 – NetScientific plc (AIM: NSCI),…
NetScientific plc (“NetScientific” or the “Company”) Portfolio Company PDS Biotechnology collaborates with Merck in Phase 2 studies for PDS0101 in metastatic…
NetScientific plc (“NetScientific” or the “Company”) Portfolio Company PDS Biotechnology to prioritise lead immunotherapy treatment in high-risk human papillomavirus (HPV) into Phase…
NetScientific plc (“NetScientific” or the “Company”) Portfolio Company PDS Biotechnology announces new positive data for lead immunotherapy treatment in high-risk human papillomavirus…
NetScientific plc (“NetScientific” or the “Company” or the “Group”) Interim Results for the six months ended 30 June 2019 Portfolio companies…
1 August 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or…
31 July 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc (“NetScientific” or…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS 1a. Identity of the issuer or the underlying…
NetScientific plc (“NetScientific” or the “Company”) Result of Annual General Meeting London, UK – 18th June 2019 – NetScientific plc…
NetScientific plc ("NetScientific" or the "Group") New data demonstrates NEATstik’s potential as a rapid bacterial monitoring tool in lung disease Published…
NetScientific plc (“NetScientific” or the “Company” or the “Group”) Notice of AGM and Annual Report & Accounts London, UK…
NetScientific plc ("NetScientific" or the "Group") NetScientific Full Year Results for the year ended 31 December 2018 London, UK…
16 May 2019 NetScientific plc ("NetScientific" or the "Company") PDS Biotechnology journal publication NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP…
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 25 April 2019 NetScientific plc (“NetScientific” or…
22 March 2019 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF EU REGULATION 596/2014 NetScientific plc ("NetScientific"…
19 March 2019 NetScientific plc ("NetScientific" or the "Company") PDS merger with Edge Therapeutics update Further to its announcements on 26 November…
18 March 2019 NetScientific plc ("NetScientific" or the "Company") PDS completes merger with Edge Therapeutics Further to its announcement 26 November 2018,…
18 March 2019 NetScientific plc ("NetScientific" or the "Company") Orderly wind up of Wanda and Vortex Further to its announcement and…
14 March 2019 NetScientific plc ("NetScientific" or the "Company") Share Price Movement NetScientific plc (AIM: NSCI) notes its recent share price movement…
Further to the announcement on 1 March 2019, NetScientific plc (AIM: NSCI) announces that at the general meeting held earlier today a…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft…
TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft…
Mon, 18th Feb 2019 16:54RNS Number : 4056QNetScientific PLC18 February 2019 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR…
London, UK – February 14, 2019 – Further to its earlier related announcement on 22 October 2018, NetScientific plc (“NetScientific”, AIM: NSCI),…
Merger would create publicly-traded immuno-oncology biotechnology company developing novel products for treating early- and late-stage cancer Growing product pipeline utilising Versamune®, a…
London, UK – 08 November 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its US-based portfolio…
London, UK – 1 November 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its US-based portfolio…
The following amendments have been made to the ‘Glycotest Completes $10m Series A Round with Fosun’ announcement (RNS Number: 6823E) released on…
NetScientific plc (“NetScientific” or the “Company” or the “Group”) NetScientific Interim Results for the six months ended 30 June 2018 …
- 1,000 patient BRIDGE study to be funded by the European Respiratory Society London, UK – 20 September, 2018 – NetScientific…
London, UK – August 15, 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that portfolio company Wanda,…
- ProteaseTag® Active Proteinase-3 Immunoassay aimed at researchers studying COPD, cystic fibrosis, and bronchiectasis London, UK – 02 August, 2018 –…
London, UK – 2nd August 2018 – NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, is delighted to announce the…
London, UK – July 18th, 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that portfolio company Wanda,…
London, UK – 26th June 2018 – NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation Group, today announced that on…
London, UK – 21st June 2018 – NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that all resolutions proposed…
London, UK – 6th June 2018 – NetScientific plc ("NetScientific", AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that its portfolio company…
London, UK – June 4th, 2018 – NetScientific plc (“NetScientific”, AIM: NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio…
London, UK – June 1st, 2018 – NetScientific plc (“NetScientific”, AIM: NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio…
London, UK – 22nd May 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that, in accordance with…
London, UK – May 21st, 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that Wanda and Health…
London, UK – May 2nd 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update for its…
18 April 2018 NetScientific plc Directors Dealing Notification NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation group, announces…
Data demonstrate the use of circulating tumour cells for identifying clinical biomarkers, such as EGFR mutations and PD-L1 expression, in patients with…
BioTrinity - Panel: AIM v NASDAQ v European Listing - What's best for you - London (24 April) Approaching the 12th consecutive…
NetScientific plc ("NetScientific" or the "Group") NetScientific Full Year Results for the year ended 31 December 2017 London, UK…
London, UK – March 19th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that Wanda Health, its…
London, UK – 13 March 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes that its portfolio company,…
London, UK – February 15th 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, provides an update on its…
London, UK – 09 February 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes that its portfolio company,…
Francois Martelet, chief executive of NetScientific PLC (LON:NSCI) caught up with Proactive’s Andrew Scott to update on developments within the IP commercialisation…
London, UK – 16 January 2018 – NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, today announces an update on its…
London, UK – January 8th 2018 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, provides an update on its…
London, UK – 05 January 2018 – NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, today announces that its management team…
London, UK – 04 January 2018 – NetScientific plc (AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that its portfolio company Glycotest…
London, UK – December 12th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces the issue by the…
London, UK – 08 December 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group announces that Francois Martelet,…
London, UK – 05 December 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes the announcement by its…
London, UK – 04 December 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group announces that Francois Martelet, Chief…
London, UK – 21 November 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes the announcement by its…
London, UK – 7 November 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes that its portfolio company,…
London, UK – November 3rd 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that HRS Home Health…
London, UK – 02 November 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that a Chinese patent…
London, UK – 1 November 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update from its…
London, UK – October 30th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes the announcement by portfolio…
London, UK – October 30th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, notes the announcement by portfolio…
London, UK – October 27th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, provides an update on its…
London, UK – 25 October 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that Jonathan Paisner, Non-Executive…
London, UK – 05 October 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that a Japanese patent…
London, UK – October 2nd 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces the issue by the…
NetScientific plc (“NetScientific” or the “Company” or the “Group”) NetScientific Interim Results for the six months ended 30 June 2017 …
London, UK – September 14th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update for its…
London, UK – September 11th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update for its…
London, UK – 7 September 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces that it will report…
London, UK – September 4th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update for its…
London, UK – July 24th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation group, announces an update for its…
London, UK – July 10th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic IP commercialisation group focused on healthcare, announces a new…
London, UK – 07 July 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic healthcare IP commercialisation Group, announces that a European patent…
London, UK – June 26th 2017 – NetScientific plc (“NetScientific”, AIM:NSCI), the transatlantic IP commercialisation group focused on healthcare, provides an update…
RNS Number : 7628I NetScientific PLC 21 June 2017 NetScientific plc ("NetScientific" or the "Company" or the "Group") Result of Annual General…
RNS Number : 3190I NetScientific PLC 16 June 2017 The following is to be read in replacement of the Holdings In Company…
READ PDF Liquid Biopsy_IV1705
NetScientific plc 170526 Annual Report and AGM (Final) (“NetScientific” or the “Company” or the “Group”) Notice of AGM and Annual Report &…
http://www.proactiveinvestors.com/companies/news/178340/netscientific-raises-up-to-98mln-as-portfolio-companies-approach-maturity-178340.html A placing and subscription at 45p will raise £8.1mln, while a further £1.5mln can come from a private placing Funds will…
04:18 24 May 2017 http://www.proactiveinvestors.com/companies/news/178249/netscientific-business-vortex-bio-kicks-off-lung-cancer-proof-of-concept-trial-178249.html These studies are designed to provide proof of principle that biomarkers used for tumour biopsises can be…
Proactive Investors One2One Investor Forum - London Redx Pharma Plc | Summit Therapeutics PLC | Netscientific PLC http://www.proactiveinvestors.com/register/event_details/104 Jun 15th 2017, 6.00…
download PDF London, UK – 10 May 2017 – NetScientific Plc (AIM: NSCI, "NetScientific", "the Group"), the transatlantic healthcare IP commercialisation Group,…
François Martelet M.D Netscientific Chief Executive Officer speaks about Netscientific transatlantic healthcare technology group. NetScientific is a transatlantic healthcare IP commercialisation group.…
Board of Directors The posts of Chairman and CEO are held by different Directors and the Board of Directors (the “Board”) is…
RNS Number : 0278S NetScientific PLC 16 December 2016 ("NetScientific" or the "Company" or the "Group") NetScientific Executed Warrants in Portfolio Company,…
RNS Number : 5206P NetScientific PLC 18 November 2016 ("NetScientific" or the "Company" or the "Group") Portfolio Company Vortex Bioscience's circulating tumour…
NetScientific plc (LON:NSCI) chief executive and chairman Francois Martelet hailed recent news from portfolio company Vortex Biosciences as a "very important" milestone.…
RNS Number : 2980O NetScientific PLC 03 November 2016 ("NetScientific" or the "Company" or the "Group") Portfolio Company Vortex Biosciences Gains CE…
RNS Number : 5249N NetScientific PLC 26 October 2016 ("NetScientific" or the "Company" or the "Group") Portfolio Company Vortex Biosciences Appoints Deborah…
RNS Number : 2638L NetScientific PLC 30 September 2016 NetScientific plc ("NetScientific" or the "Company" or the "Group") ProAxsis Gains CE Mark…
RNS Number : 8784K NetScientific PLC 27 September 2016 NetScientific plc ("NetScientific" or the "Group") NetScientific Interim Financial Information…
Biomedical and healthcare incubator NetScientific PLC (LON:NSCI) had a busy first half to the year, focusing on “execution, execution, execution”, according to…
RNS Number : 6195K NetScientific PLC 23 September 2016 NetScientific plc ("NetScientific" or the "Company" or the "Group") Wanda Technology Selected by…
RNS Number : 4947J NetScientific PLC 12 September 2016 ("NetScientific" or the "Company" or the "Group") Glycotest Strengthens Intellectual Property Portfolio with…
RNS Number : 2460J NetScientific PLC 08 September 2016 ("NetScientific" or the "Company" or the "Group") Wanda Strengthens its Board with Digital…
RNS Number : 0032J NetScientific PLC 06 September 2016 ("NetScientific" or the "Company" or the "Group") Notice of Interim Results…
RNS Number : 6055H NetScientific PLC 19 August 2016 ("NetScientific" or the "Company" or the "Group") myWanda Mobile App Launches to…
RNS Number : 5166H NetScientific PLC 18 August 2016 ("NetScientific" or the "Company" or the "Group") Vortex Biosciences Appoints Leading Experts…
RNS Number : 0608G NetScientific PLC 03 August 2016 ("NetScientific" or the "Group") Vortex Biosciences Announces Exclusive License…
RNS Number : 4527F NetScientific PLC 28 July 2016 ("NetScientific" or the "Company" or the "Group") Change of Adviser London, UK…
RNS Number : 3124F NetScientific PLC 27 July 2016 ("NetScientific" or the "Company" or the "Group") Wanda Names Dr. Suzanne Steinbaum,…
RNS Number : 9291E NetScientific PLC 22 July 2016 ("NetScientific" or the "Company" or the "Group") A to Z Home Health…
RNS Number : 2799C NetScientific PLC 27 June 2016 ("NetScientific" or the "Company" or the "Group") Grant of Options to Director London,…
RNS Number : 3020B NetScientific PLC 15 June 2016 ("NetScientific" or the "Company" or the "Group") Results of Annual General Meeting…
RNS Number : 0706B NetScientific PLC 14 June 2016 ("NetScientific" or the "Company" or the "Group") Vortex Biosciences appoints Dr. Massimo…
RNS Number : 0709B NetScientific PLC 14 June 2016 14 June 2016 NetScientific plc ("NetScientific" or the "Group") NetScientific hosts…
RNS Number : 8030A NetScientific PLC 10 June 2016 ("NetScientific" or the "Company" or the "Group") Netscientific Confirms Start Date for…
RNS Number : 3753A NetScientific PLC 07 June 2016 NetScientific plc ("NetScientific" or the "Company" or the "Group") NetScientific Portfolio PDS…
RNS Number : 9816Y NetScientific PLC 23 May 2016 NetScientific ("NetScientific" or the "Company" or the "Group") Notice of AGM and Annual…
RNS Number : 4509V NetScientific PLC 18 April 2016 NetScientific ("NetScientific" or the "Company" or the "Group") NetScientific portfolio company…
RNS Number : 0007V NetScientific PLC 13 April 2016 NetScientific plc ("NetScientific" or the "Company" or the "Group") NetScientific Portfolio Company…
RNS Number : 4343U NetScientific PLC 07 April 2016 7 April 2016 NetScientific plc ("NetScientific" or the "Group") NetScientific Full…
RNS Number : 1367U NetScientific PLC 05 April 2016 ("NetScientific" or the "Company" or the "Group") Netscientific Appoints Ian Postlethwaite as…
RNS Number : 4656T NetScientific PLC 30 March 2016 ("Netscientific" or the "Group") ProAxsis Forms Scientific Advisory Board to…
RNS Number : 1205T NetScientific PLC 24 March 2016 ("NetScientific" or the "Company" or the "Group") Notice of Results London, UK…
RNS Number : 2148S NetScientific PLC 16 March 2016 ("NetScientific" or the "Group") Wanda Forms Scientific Advisory Board…
RNS Number : 2859R NetScientific PLC 07 March 2016 NetScientific plc Adoption of the reduced disclosure framework within Financial Reporting Standard (FRS)…
RNS Number : 6459Q NetScientific PLC 01 March 2016 NetScientific plc Vortex BioSciences co-founder receives US Presidential award for groundbreaking…
RNS Number : 3883Q NetScientific PLC 29 February 2016 NetScientific plc Wanda™ partners with leading US Hospital Group Dignity Health™ to launch…
RNS Number : 2646P NetScientific PLC 17 February 2016 NetScientific plc NetScientific appoints Professor Stephen Smith as Non-Executive Director London,…
RNS Number : 5158O NetScientific PLC 09 February 2016 NetScientific plc PDS Biotechnology partners with National Cancer Institute in Phase II…
RNS Number : 4149O NetScientific PLC 08 February 2016 NetScientific plc Grant of Options to Director London, UK - 8 February…
RNS Number : 9451M NetScientific PLC 26 January 2016 NetScientific plc Board Change London, UK - 26 January 2016 - NetScientific…
RNS Number : 4379M NetScientific PLC 20 January 2016 NetScientific plc PDS Biotechnology appoints Chief Medical Officer and VP of Drug…
RNS Number : 9237K NetScientific PLC 06 January 2016 NetScientific plc NetScientific portfolio company, Glycotest Inc., appoints world…
RNS Number : 6412K NetScientific PLC 04 January 2016 NetScientific plc WANDA signs contract with leading US home nursing…
RNS Number : 1865J NetScientific PLC 16 December 2015 NetScientific appoints diagnostics leader Lawrence Cohen as CEO of Glycotest Inc. …
RNS Number : 8771I NetScientific PLC 14 December 2015 NetScientific plc Ex Novartis Diagnostics president, Gene Walther is appointed CEO of…
RNS Number : 8155H NetScientific PLC 03 December 2015 NetScientific plc ProAxsis' ProteaseTag™ technology shown to effectively monitor patients with chronic…
RNS Number : 2866H NetScientific PLC 30 November 2015 NetScientific plc ProAxsis presents new data to validate its ProteaseTag™ Active…
RNS Number : 7571F NetScientific PLC 16 November 2015 NetScientific PLC ("NetScientific" or the "Group") London, UK - 16 November…
RNS Number : 2698F NetScientific PLC 11 November 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or…
RNS Number : 1137F NetScientific PLC 10 November 2015 NetScientific PLC ("NetScientific" or the "Group") Grant of Options to Director …
RNS Number : 8824E NetScientific PLC 06 November 2015 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR…
RNS Number : 7886E NetScientific PLC 06 November 2015 THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR…
RNS Number : 4417E NetScientific PLC 03 November 2015 For filings with the FCA include the annex For filings with issuer exclude…
RNS Number : 9468C NetScientific PLC 21 October 2015 NetScientific plc ("NetScientific" or the "Company") Posting of Circular 21 October…
RNS Number : 8339A NetScientific PLC 01 October 2015 NetScientific plc ('NetScientific or the 'Company' or the 'Group') Half Year…
RNS Number : 8342A NetScientific PLC 01 October 2015 THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND…
RNS Number : 4497Z NetScientific PLC 18 September 2015 NetScientific plc Divestment of shareholding in Frontier BioSciences and realignment of resources…
RNS Number : 2576Z NetScientific PLC 16 September 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer…
RNS Number : 0312Z NetScientific PLC 15 September 2015 NetScientific plc Vortex BioSciences granted critical patent for its Liquid Biopsy…
RNS Number : 5652Y NetScientific PLC 09 September 2015 NetScientific plc NetScientific announces the key appointment of Steve Curd…
RNS Number : 3824V NetScientific PLC 07 August 2015 NetScientific plc NetScientific divests non-core assets to align its healthcare portfolio …
RNS Number : 9521U NetScientific PLC 04 August 2015 NetScientific plc ProAxsis launches first-in-class ProteaseTagTM test for Cystic Fibrosis and Chronic…
RNS Number : 0582T NetScientific PLC 15 July 2015 NetScientific plc Significant European patent granted on Glucosense Diagnostics technology…
RNS Number : 8379Q NetScientific PLC 22 June 2015 NetScientific plc Results of Annual General Meeting …
RNS Number : 7804Q NetScientific PLC 22 June 2015 NetScientific plc Annual General Meeting London, UK - 22 June 2015 - NetScientific…
RNS Number : 4404P NetScientific PLC 05 June 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or…
RNS Number : 4401P NetScientific PLC 05 June 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or…
RNS Number : 4400P NetScientific PLC 05 June 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or…
RNS Number : 4038P NetScientific PLC 05 June 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or…
RNS Number : 4034P NetScientific PLC 05 June 2015 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer or…
RNS Number : 5095O NetScientific PLC 28 May 2015 NetScientific plc ("NetScientific" or the "Group") PDS Biotechnology reports positive Phase I…
RNS Number : 4055N NetScientific PLC 18 May 2015 NetScientific plc ("NetScientific" or the "Group") Annual Report and Accounts London,…
RNS Number : 2602N NetScientific PLC 15 May 2015 NetScientific plc ("NetScientific" or the "Group") Capital Markets Day …
RNS Number : 7136M NetScientific PLC 11 May 2015 NetScientific plc ("NetScientific" or the "Group") NetScientific appoints Dr. François R.…
RNS Number : 4149M NetScientific PLC 07 May 2015 NetScientific plc ("NetScientific" or the "Group") NetScientific invests in wearable…
RNS Number : 9480L NetScientific PLC 01 May 2015 NetScientific plc ("NetScientific" or the "Group") NetScientific forms digital health company with…
RNS Number : 6699L NetScientific PLC 29 April 2015 NetScientific plc ("NetScientific" or the "Group") Capital Markets Day…
RNS Number : 0844J NetScientific PLC 01 April 2015 NetScientific plc Appointment of Adviser London, UK - 1 April 2015 -…
RNS Number : 2522I NetScientific PLC 24 March 2015 NetScientific plc ('NetScientific' or the 'Group') NetScientific Full Year results: Significant Progress…
RNS Number : 0638I NetScientific PLC 20 March 2015 NetScientific plc ("NetScientific" or the "Group") Notice of Full Year Results London,…
RNS Number : 9575F NetScientific PLC 26 February 2015 NetScientific plc ("NetScientific" or the "Group") Appointment to the Board…
RNS Number : 4483C NetScientific PLC 16 January 2015 NetScientific plc ("NetScientific" or the "Group") NetScientific announces departure of Chief…
RNS Number : 5259B NetScientific PLC 07 January 2015 NetScientific plc ("NetScientific" or the "Group") NetScientific teams up with KU Leuven…
RNS Number : 5253B NetScientific PLC 07 January 2015 NetScientific plc ("NetScientific" or the "Group") NetScientific announces investment in DName-iT bringing…
RNS Number : 7136Z NetScientific PLC 15 December 2014 NetScientific plc ('NetScientific' or 'the Group') NetScientific Invests in Next Generation,…
RNS Number : 4502Z NetScientific PLC 11 December 2014 NetScientific plc ('NetScientific' or 'the Group') NetScientific enters into an alliance…
RNS Number : 0499Z NetScientific PLC 08 December 2014 NetScientific plc ('NetScientific' or 'the Group') NetScientific invests in Breakout Labs'…
RNS Number : 2346X NetScientific PLC 17 November 2014 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer…
RNS Number : 2097X NetScientific PLC 17 November 2014 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer…
RNS Number : 3461T NetScientific PLC 03 October 2014 NetScientific plc ('NetScientific' or 'the Group') NetScientific's subsidiary, Glycotest Begins a…
RNS Number : 3136S NetScientific PLC 23 September 2014 NetScientific plc ('NetScientific' or 'the Company' or 'the Group') Half-Yearly…
RNS Number : 9340R NetScientific PLC 17 September 2014 NetScientific plc ('NetScientific' or 'the Company')…
RNS Number : 6569N NetScientific PLC 29 July 2014 NetScientific announces significant shareholder name change NetScientific plc (AIM:NSCI, 'NetScientific' or 'The…
RNS Number : 0808N NetScientific PLC 23 July 2014 23 July 2014 NetScientific invests in a further two Breakout…
RNS Number : 8531M NetScientific PLC 21 July 2014 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer…
RNS Number : 1064M NetScientific PLC 11 July 2014 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer…
RNS Number : 5298L NetScientific PLC 04 July 2014 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi 1. Identity of the issuer…
RNS Number : 1276L NetScientific PLC 02 July 2014 NetScientific plc ('NetScientific' or the 'Group') Research Programme in DNA…
RNS Number : 1943J NetScientific PLC 09 June 2014 NetScientific plc NetScientific plc (AIM:NSCI, 'NetScientific' or 'the Company'), the biomedical and…
RNS Number : 5261H NetScientific PLC 20 May 2014 NetScientific plc AGM Statement At the Company's Annual General Meeting to be…
RNS Number : 6276H NetScientific PLC 20 May 2014 NetScientific plc Result of AGM NetScientific is pleased to announce that…
RNS Number : 3950H NetScientific PLC 19 May 2014 NetScientific announces research agreement with Harvard University NetScientific plc (AIM:NSCI,…
RNS Number : 5906G NetScientific PLC 08 May 2014 NetScientific plc ('NetScientific' or the 'Group') Posting of Annual Report…
RNS Number : 1817D NetScientific PLC 26 March 2014 NetScientific Partners with Peter Thiel's Breakout Labs to Increase Support for Companies…
RNS Number : 6281C NetScientific PLC 19 March 2014 NetScientific plc ('NetScientific' or the 'Group') Preliminary results for the…
RNS Number : 2763C NetScientific PLC 13 March 2014 Netscientific plc ('Netscientific' or 'the Company') Notification of Results Netscientific,…
RNS Number : 7384A NetScientific PLC 24 February 2014 24 February 2014 NetScientific plc ("NetScientific" or the "Group")…
RNS Number : 1835P NetScientific PLC 30 September 2013 30 September 2013 NetScientific plc ("NetScientific" or the "Group") Director Dealings…
RNS Number : 0585P NetScientific PLC 27 September 2013 NetScientific plc ('NetScientific' or the 'Group') Interim results for the six months…
RNS Number : 0184O NetScientific PLC 16 September 2013 NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN, AUSTRALIA OR THE…
NetScientific plc
20 St. Andrew Street
London, EC4A 3AG
Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net
Copyright 2022
Netscientific PLC, Author at NetScientific